WASHINGTON, Dec. 23, 2024 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company”), pharmaceutical...
The UNITY Prenatal Test Expands Access to Maternal Care in Remote Communities, Reducing Travel Burdens for High-Risk Pregnancies MENLO PARK,...
BOERNE, Texas, Dec. 20, 2024 /PRNewswire/ -- Prytime Medical, The REBOA Company™, is proud to announce significant strides made in...
COPENHAGEN, Denmark, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that YORVIPATH® (palopegteriparatide; developed as...
Recognized for discovery of cell-free fetal DNA in maternal blood and creation of noninvasive prenatal testing (NIPT), used by as...
Aeroflow Breastpumps won the state RFP in Montana to provide mothers under Medicaid with electric breast pumps and other maternal...
Pylo 900-LTE blood pressure monitor is now clinically validated and FDA cleared for use during pregnancy, addressing the ongoing crisis...
Data Shows Pomelo's Virtual Care Model Reduces Total Cost of Maternal Care in Medicaid Population, Lowers NICU and ER Utilization for...
The trial (NCT06207370) evaluates tafenoquine combined with standard treatment for babesiosis, addressing a critical unmet medical need.The clinical site is...
Presentations complement topline data with new data from two pivotal studies (Studies 501 and 502) evaluating lumateperone as an adjunctive...
JACKSONVILLE, Fla.--(BUSINESS WIRE)--To help ensure more families have access to educational resources they need for healthy birth outcomes, the Northeast...
JACKSONVILLE, Fla.--(BUSINESS WIRE)--To help ensure more families have access to educational resources they need for healthy birth outcomes, the Northeast...
Combining Advanced Remote Patient Monitoring Technology with Comprehensive Virtual Maternity Services AUSTIN, Texas and ST. PAUL, Minn., Dec. 6, 2024...
DARIEN, Conn., Dec. 3, 2024 /PRNewswire/ -- Medical device maker CEFALY Technology today launched the CEFALY Pregnancy Registry, a new...
The sNDA submission is based on positive results from Studies 501 and 502 demonstrating CAPLYTA’s robust antidepressant efficacy and favorable...
The world-first tailored care plans address over 40 conditions, including Polycystic Ovary Syndrome (PCOS), Endometriosis, Gestational Diabetes, Preeclampsia, and more....
MIAMI, FL, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...
Trial results demonstrated safety and effectiveness of FemaSeed intratubal insemination with high satisfaction ratings from both practitioners and patientsATLANTA, Nov....
- Attruby is the first and only approved product with a label specifying near-complete stabilization of TTR. Attruby has been...
PHILADELPHIA, Nov. 20, 2024 /PRNewswire/ -- PolicyMap, an online data and mapping company, announced today the integration of Surgo Health's' Granular...